Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You would be surprised. Lol
Sounds about right to me! Time for this baby to wake up. Sounds like (INQR & Team) has been putting in some work over here and is ready to take care of (RNVA) with a possible nice update on payback date. Wow! Patience and more Patience with a positive attitude . I like the (Reward to risk) Hello!!!!!!!!🤑🤑🤑🤑🤑. Go (INQR & Team)
no one wants to buy a stock with a 168m float and an incompetent ceo threatening massive rs. no one is that stupid.
Whoever runs this company, as long as Gerard Dab has his hand in it, there will be no end to this miserable spectacle.
look at the new ceo of RITE by contrast. Peterson is a disgrace. James B is more confident in his big float stock than pathetic peterson is with a low float. Night and day. Commons get wrecked here 100 RS coming any day from the clown show
The falling share price reflects the inability of the management.
Cats are getting ready to pounce:))
Play with their prey??????
No worries! There’s this extremely multimillionaire worth almost 100 milly. He said he and his group will devour up all these cheap shares.
Wat een lul verhaal heeft die Petersons vandaag weer.
no one wants this pitiful stock at 0035 yet they want to exchange commons for 005 . this thing is so screwed. every stock is running except this one.
worst stock in otc. low float with incompetent management. every stock is running except this failure ran by losers worst ceo in otc wants to rs because he cant handle the pressure of being worthless prick
short term 100 reverse split then AS raise in otc to 3.5b guess what is next massive dilution.
no one buys this stock since the interview confirming rs . no one is that stupid apparently. this is a dab peterson disaster and everyone knows it
petersons threatening proposal of exchange your shares or get RS is the lowest thing any pennystock otc has ever said. Absolute lunatic running the show over there. Vote to fire the fraud he cant even handle a low float of 168m hes in over his head. Inqr needs a new ceo who doesnt suck donkey balls asap
all my time in otc never seen a worse stock and more incompetent loser ceo than what we have here with inqr. and thats saying a lot. lost all confidence in my holdings as a shareholder and no faith these idiots can deliver a meaningful, profitable run to public holders. absolute filth here lowest of the low running this pathetic S show
the fact loser senile peterson wants commons to exchange their shares for some bogus bs e/f shares or whatever ...otherwise he will rs on a 168m float says it all. how dare he threaten commons like that. This went from Holly to Seamus to this goddamn clown out of nowhere on his high horse acting like hes some hot shot running a fortune 500 company
BUYER BEWARE 1:100 reverse split on the way peterson is drafting the filing already to be submitted soon DONT WALK RUN from this blatant failure
hate to bash my own stock but so what this disaster needs to be bashed it's a pos run by imbeciles who clearly hate their shareholders they have a vendetta against outsiders sickening bunch of creeps running the show
the fact they will file for RS with a float of 169m against a 3.5b AS exactly proves management is a bunch of incompetent scum
they are painting themselves as some hot shot big time big deal company when they are nothing more than typical otc subpenny trash hahah the level of delusion coming from management is unbearable.
yeah peterson you are really going to attract real investors with all the offerings, dilution, and threats of rs. this new ceo is the lowest of the low, lower than dog crap on a dirty bum's beat up crocs. greedy pig peterson is disgrace to shareholders. no one will ever take a creep like him seriously
ceo believes rs will attract institutional investors loool they will never touch this inqr/curallo dumpster fire dilutive scam. he wants to rs because he is a greedy old incompetent hater who wants maximum room to dilute the upcoming 3.5b AS . Never heard a more selfish scummy "ceo" in all of otc. peterson, dab, etc all these bad actors are truly miserable clueless lowlives
If the company continues to deliver such pathetic performance, the reverse split is guaranteed to happen. That is as sure as the "Amen" in the church.
Quote:
Peterson stated that it was not possible to guarantee the Company will not have to complete a reverse split but confirmed the intention to do everything possible to avoid one.
https://www.innovaqor.com/investors/news-events/press-releases/detail/55/innovaqor-inc-provides-update-on-curallo-product-and
warning everyone to stay far away from this stock. it is run by a complete idiot who only wants to make money for himself and no one else. Buying inqr will only result in loss. i will lose my entire "investment" so what at least i can warn others to not make the same mistake especially since this garbage loser miserable senile bastard peterson took over he is lowest scum rat trash who will only steal your money and offer nothing in return bc hes a hater
who do they think they are ? no one wants this at .0048 lol why would anyone want class shares at .005 . grandiose sense of delusion over there at inqr they think they are a big time nasdaq stock hellooooo it's a trash penny do they understand that or are they stupid. no one going to buy any kind of stock from otc trash especially one with a senile ceo threatening rs my gosh inqr is a massive blunder ridden failure
pererson is one delusional fool to think inqr otc pennystock trash is somehow big board nasdaq quality status. hes completely stupid to think anyone would want to "invest" in this subpenny trash otc especially with how badly the market performs no one trust it. peterson is the worst thing to happen to inqr. he wont fire dab but he will dilute/rs and wont ever deliver the epic run inqr would have had under a competent, good leader
no one wants your stock at all period peterson whether common or e/f whatever doesnt matter no one buying this lame 2 bit scam. oh but he wants to rs to raise pps to attract who exactly? lol. no hedgefund gonna invest in this scam.
YOU HAVE BEEN WARNED, HUGE WARNING:
do not make the mistake we made by gambling on this horrible stock. been holding since vmcs just to get screwed by this new scumbag incompetent inept screwball nutbag looney tunes peterson he suuucks. DO NOT BUY INQR THEY ARE JUST GOING TO DILUTE THEN REVERSE SPLIT THIS COMPANY IS A FRAUD THEY NEVER INTEND ON RUNNING THE STOCK AS TO VALUE ANY OUTSIDER SHAREHOLDER WHETHER COMMONS OR F/E STOCK WILL ONLY GET SCREWED BY THAT IDIOT
AVOID INQR AT ALL COSTS DO NOT BUY THIS HOT SCAM MEANT TO STEAL YOUR MONEY THEN BURY YOU
what common would ever want d e xyz "class" shares of some loser otc penny stock !?! no one ! peterson is such a loser. 005 in 3 years what 3 years this isnt big board peterson you arrogant nitwit this is a stupid pennystock no one cares about. all of this is frustratingly stupid asinine peterson is such an inept creep
peterson is an awful, terrible, travesty of a so called "ceo". he cant handle a low float of 168m lol wow. hes absolutely insane- that stockday he just did is the most stressful thing ever heard. He is totally incompetent, he hates commons, it is clear he wants to RS asap. That interviewer did a good job of exposing what a crooked, vile, disconnected, aloof, psycho he is. Why does he hate commons so much?? what is his problem with common holders!?! Why did that lowlife have to come along to ruin everything... Why couldnt a good ceo who knows what he is doing take over instead. game over at inqr where commons get screwed
peterson is trying to promote his new stock over commons. no one will take that. this is such a disgusting sick joke. they are going to rs for sure what a failure.
CURALLO is on youtube. Also a short version on the Innovaqor/curallo website. You have to register first to view the full version. IT LOOKS GREAT!
website updated they have a youtube now apparently. they have a 168m low float talking about rs lol . otc doesnt run low floats anymore only mid-high with no story
offerings, as raise, dilution, debt, even though the float is LOW they threaten rs so they can dilute from the floor up. Name one good thing about them . they are audited and cannot even prove "20m" in assets they are broke. the only way they can make any money is by diluting and they are so cheap and dont care that they will dilute at .0001
yeah really wonderful pr peterson. put out 10000000 filings and prs your crappy stock is still double 0 subpenny trash no matter what you do apparently
a reverse split lol. worst news ever. investing in this loser trash company run by absolute incompetent scum is the worst decision ever made. what a shame
INNOVAQOR, INC. CREATES PREFERRED STOCK; CONSIDERS LAUNCHING EXCHANGE OFFER TO COMMON SHAREHOLDERS
November 27, 2023 09:00 ET
| Source: InnovaQor, Inc.
WEST PALM BEACH, Fla., Nov. 27, 2023 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: INQR) authorized two new series of preferred stock, the Series E Mandatory Convertible Preferred Stock and the Series F Mandatory Convertible Preferred Stock, by filing certificates of designation with the Secretary of State of the State of Nevada on November 22, 2023. The Company authorized the two series of preferred stock in contemplation of a potential exchange offer to be made to its common shareholders.
The Company is considering offering common shareholders the opportunity to exchange common shares for a stated value of Series E and Series F Preferred Stock. The value of common shares exchanged would be divided equally between Series E and Series F Preferred Stock. The Series E Preferred Stock has a mandatory conversion date of December 31, 2026 and the Series F Preferred Stock has a mandatory conversion date of December 31, 2027. The stated value each series of preferred stock initially is $100, and increases by $20 upon each anniversary of issuance.
As an example, as currently contemplated, if a common shareholder exchanges $1,000 of common shares they will receive $500 of Series E Preferred Stock and $500 of Series F Preferred Stock.
The $500 of Series E Preferred Stock shall have a stated value of (i) $600 from the first anniversary of the original issue date until the day before the second anniversary of the Original Issue Date; and (ii) $700 from and after the second anniversary of the original issue date until the day before the third anniversary of the original issue date; and (iii) $800 on the third anniversary until the mandatory conversion date at which time the total stated value of the Series E Preferred Stock ($800.00) would automatically convert to common stock of the Company at the average closing price of the Common Stock on the 10 Trading Days immediately prior to the mandatory conversion date.
The $500 of Series F Preferred Stock shall have a stated value of (i) $600 from the first anniversary of the original issue date until the day before the second anniversary of the Original Issue Date; and (ii) $700 from and after the second anniversary of the original issue date until the day before the third anniversary of the original issue date; and (iii) $800 from and after the third anniversary of the original issue date until the day before the fourth anniversary of the original issue date; and (iv) $900 on the fourth anniversary until the mandatory conversion date at which time the total stated value of the Series F Preferred Stock ($900.00) would automatically convert to common stock of the Company at the average closing price of the Common Stock on the 10 Trading Days immediately prior to the mandatory conversion date.
“We believe an exchange offer is a viable and exciting alternative to completing a reverse split of our common stock in an effort to make our Company more attractive to new investors” said Darrell Peterson, CEO of InnovaQor, Inc. “Our Company is entering a phase where new investors are necessary to help us create a significantly more valuable Company. If successful, an exchange offer would create more opportunity to our current shareholders than other methods of restructuring our current capitalization to attract investment.”
The terms and timing of an exchange offer are subject to final approval by the Board of Directors of the Company and market conditions.
News today November 27th 2023:
InnovaQor, Inc. (INQR) authorizes two new series of preferred stock, Series E and Series F, for potential exchange offer to common shareholders. The Series E Mandatory Convertible Preferred Stock has a mandatory conversion date of December 31, 2026, and the Series F Mandatory Convertible Preferred Stock has a mandatory conversion date of December 31, 2027. The stated value of each series of preferred stock initially is $100, increasing by $20 upon each anniversary of issuance. The exchange offer is being considered as an alternative to completing a reverse split of common stock to attract new investors. The terms and timing of the exchange offer are subject to final approval by the Board of Directors and market conditions.
This is what I wrote a while ago (see Intro) about Curallo:
InnovaQor is a kind of a pioneer in the domain of creating a social platform for physicians, creating a networking, knowledge sharing, and hiring mechanism along the lines of LinkedIn. There is a global shortfall of 4.3 million doctors, nurses, and other healthcare professionals. Through its platform Curallo.com, INQR primarily targets physician groups, facilities and associations trying to acquire advocacy through the larger governing boards with a member-exclusive discount.
The revenue streams of this social media platform would include freemium, premium subscription fees, sponsorship, talent search per individual/ facility, and so on. As LinkedIn has shown, there is a need for additional access, knowledge, and connectivity, which comes with a monthly premium access fee. In fact, LinkedIn’s data indicates that individuals are willing to spend $30, while corporations are willing to pay $60 for such services which means INQR definitely can earn strong revenues from its niche.
The Talent Search Subscription Program (TSSP) is anticipated to upend the market by utilizing AI for matchmaking based on user profile optimization. The TSSP feature on LinkedIn generates 65% of the company's revenue, displacing market leaders like Monster and Indeed. With INQR/Curallo employing an industry-specific model, TSSP is a boon for healthcare professionals, especially in todays hiring market. Large pharma would find the platform to be alluring for advertising with an engaged industry audience as well. Thus, this new platform could be a huge revenue catalyst for INQR.
From what I heard the curallo MVP is complete. The outside funding that INQR needs is tied to the MVP. Not only does INQR need 2.5 million dollar to repay former parent Rennova, but they also need cash to further develop the healthcare modules. Before this year ends INQR has to repay RNVA's promissory note receivable and therefore I expect news very soon.
no one will fund this lame disaster. "outside partner" these clowns have no help they left themselves out to dry. this is indebted, no asset having broke trash stock is worthless no one wants anything to do with it
CURALLO? The company is not even able to realize the announced minimum viable product (MVP) to demonstrate their platform. LOL
Quote:
InnovaQor is building a Minimum Viable Product (MVP) to demonstrate our platform. This part of our project should be complete by the end of September 2023.
https://curallo.com/status/
The quarterly financials were filed yesterday. No big surprises, BUT former parent Rennova is pouring in more loans to enable InnovaQor to develop their Medical Professionals Communication Platform called CURALLO. In total loans from Related parties (Rennova) add up to $2,466,085. A while ago the CEO of Rennova said in an interview that he expects to get it all repaid as soon as Innovaqor gets fully funded from an outside partner. That funding is expected as/when the Curallo peer-to-peer communication module is ready and accepted. I'm expecting news any moment now.
SEC Filing Alert
NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
I stand by it, as long as this Gerard Dab continues to have his fingers in the game, nothing will come of this stock. A pity!
if this ever gets a fair run i take it all back and apologize to management until then.... the offerings. the PRs. the constant change in "ceo". name change. audited/state filings. yet the impending dilution, the lack of communication, no one seems to care. so far so flop
for a low float l2 sure is thick. what a waste
watch this disaster sink in to oblivion. what a loser stock run by incompetent scum
1 million wall at 005 no one touches it. no one wants this disaster . Huge dilution. Peterson is also director of another otc ticker which is highly sus .
I was a big fan of Innovaqor, looked very solid, but I have my doubts now. Seems the new CEO is a jerk, not explaining what’s going on. Why all recent filings with the SEC, new management and so on? Innovaqor has become a typical Pink Sheets company. Pity
900 at 005 what happened !?! such garbage trash ! dab, peterson are garbage this stock is screwed !!
Credibility is ZERO. The company's announcements still cannot be trusted.
Quote:
InnovaQor is building a Minimum Viable Product (MVP) to demonstrate our platform. This part of our project should be complete by the end of September 2023.
https://curallo.com/status/
Followers
|
73
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2832
|
Created
|
11/20/06
|
Type
|
Free
|
Moderators |
InnovaQor is a kind of a pioneer in the domain of creating a social platform for physicians, creating a networking, knowledge sharing, and hiring mechanism along the lines of LinkedIn. There is a global shortfall of 4.3 million doctors, nurses, and other healthcare professionals. Through its platform Curallo.com, InnovaQor primarily targets physician groups, facilities and associations trying to acquire advocacy through the larger governing boards with a member-exclusive discount. The revenue streams of this social media platform would include freemium, premium subscription fees, sponsorship, talent search per individual/ facility, and so on. As LinkedIn has shown, there is a need for additional access, knowledge, and connectivity, which comes with a monthly premium access fee. In fact, LinkedIn’s data indicates that individuals are willing to spend $30, while corporations are willing to pay $60 for such services which means InnovaQor definitely can earn strong revenues from its niche. The Talent Search Subscription program is anticipated to upend the market by utilizing AI for matchmaking based on user profile optimization. The Talent Solutions feature on LinkedIn generates 65% of the company's revenue, displacing market leaders like Monster and Indeed. With InnovaQor/Curallo employing an industry-specific model, TSSP is a boon for healthcare professionals, especailly in todays hiring market. Large pharma would find the platform to be alluring for advertising with an engaged industry audience as well. Thus, this new platform could be a huge revenue catalyst for InnovaQor.
ClinLab is a proprietary Windows-based, Internet and web-enabled laboratory information management system. Designed by medical technologists, ClinLab is scalable from small point-of-care labs to large multi-user, multi-location clinical facilities. ClinLab acts as a data warehouse for lab results and includes reporting, data acquisition, label printing, electronic signoff and provides numerous interface capabilities to a multitude of reference labs and practice systems.
Healthcare Technology Solutions (HTS) Virtual Chief Information Officer (vCIO) services provides one-stop, specialized IT services for healthcare facilities which enhance business operations and encourage sustainable growth. Our services focus on infrastructure-related management and we ensure you maintain a competitive advantage with innovative technology solutions. With HTS's vCIO services, organizations gain access to best-in-class managed IT and cloud solutions without the headaches of supporting an in-house staff.
Qira analytics integrates data across your entire business – streamlining operations that improve services, reporting and financial health.
MEDtuning delivers Personalized Medicine to modern clinical practices. MEDtuning develops revolutionary PhyzioType Systems for DNA-guided management and prescription of drugs used to treat mental illness, pain, heart disease, and diabetes. These systems are designed to provide physicians with an unprecedented capability to select for each patient the safest and most effective drug to achieve treatment goals and enhance patient compliance.
WEST PALM BEACH, Fla., Sept. 28, 2022 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: VMCS), today announced that it became a fully SEC reporting company on September 27, 2022 when its Form 10-12G that was filed on September 7, 2022 became effective.
For more information:
https://www.innovaqor.com/
https://medicalmime.com/
https://healthtechnologysolutions.com/analytics/
https://healthtechnologysolutions.com/vcio-services/
https://clinlabinc.com/
https://www.otcmarkets.com/stock/VMCS/security
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |